We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Consider Investing in IDEX Stock Now
Read MoreHide Full Article
Key Takeaways
IEX's HST organic sales rose 12%, while orders jumped 47%, extending backlog visibility into 2027.
IDEX raised its 2026 organic sales growth outlook to 5-6% on stronger HST orders and industrial demand.
Acquisitions added 1% to second-quarter sales, while dividends returned value to shareholders.
IDEX Corporation (IEX - Free Report) is benefiting from sustained demand in data center power, semiconductor, space and defense markets. Accretive acquisitions and shareholder-friendly policies also bode well.
IEX currently carries a Zacks Rank #2 (Buy). Let’s delve into the factors that have been aiding the firm for a while now.
Business Strength: IDEX is benefiting from demand across data center, semiconductor, space and defense markets within the Health & Science Technologies (HST) segment, while municipal water and mining continue to support the Fluid & Metering Technologies (FMT) segment. In second-quarter 2026, HST organic sales rose 12% and organic orders increased 47%, extending backlog visibility into 2027. FMT organic sales increased 1% and orders rose 11%, with water and mining gains partly offset by energy, agriculture and chemical softness. The company raised its 2026 organic sales growth outlook to 5-6% from 3-4%, supported by a larger HST order book and improving demand in its industrial businesses. This mix of secular and industrial demand is expected to support IDEX’s growth beyond the latest quarter.
Accretive Acquisition: IDEX continues to undertake acquisitions to expand its technology portfolio and reach higher-value markets. In second-quarter 2026, acquisitions added 1% to consolidated sales growth and 2% to HST sales growth, reflecting Micro-LAM, acquired in July 2025. Consolidated organic sales also rose 5% in second-quarter 2026, alongside the 1% acquisition/divestiture contribution. Micro-LAM expands IDEX’s optics technology offerings within HST. The September 2024 acquisition of Mott for $1 billion added applied materials science capabilities and broadened the company’s exposure to semiconductor fabrication, medical technologies and water purification.
In the past year, the company’s shares have gained 36.2% against the industry‘s 0.7% decline.
Image Source: Zacks Investment Research
Rewards to Shareholders: IEX is committed to returning value to shareholders through dividend payments and share repurchases. In second-quarter 2026, the company paid about $54 million in dividends and repurchased $77 million of shares. For the first six months of 2026, dividend payments totaled $106.7 million compared with $105.9 million a year earlier, while cash paid for share repurchases increased to $153.4 million from $100 million.
Estimate Revisions: The Zacks Consensus Estimate for IEX’s 2026 earnings is pegged at $8.82 per share, indicating an increase of 3.9% from the 60-day-ago figure. The consensus estimate for 2027 earnings is pegged at $9.68 per share, indicating a rise of 24.6% in the same period.
Other Stocks to Consider
Some other top-ranked companies from the same space are discussed below:
The company delivered a trailing four-quarter average earnings surprise of 13.7%. In the past 60 days, the consensus estimate for GNRC’s 2026 earnings has increased 8.5%.
Applied Industrial Technologies (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). It has a trailing four-quarter average earnings surprise of 4.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2027 earnings has increased 1.7% in the past 60 days.
Helios Technologies (HLIO - Free Report) currently carries a Zacks Rank of 2. HLIO delivered a trailing four-quarter average earnings surprise of 13.1%.
In the past 60 days, the Zacks Consensus Estimate for Helios Technologies’ 2026 earnings has increased 10.4%.
View the Zacks #1 Rank List
Image: Bigstock
Here's Why You Should Consider Investing in IDEX Stock Now
Key Takeaways
IDEX Corporation (IEX - Free Report) is benefiting from sustained demand in data center power, semiconductor, space and defense markets. Accretive acquisitions and shareholder-friendly policies also bode well.
IEX currently carries a Zacks Rank #2 (Buy). Let’s delve into the factors that have been aiding the firm for a while now.
Business Strength: IDEX is benefiting from demand across data center, semiconductor, space and defense markets within the Health & Science Technologies (HST) segment, while municipal water and mining continue to support the Fluid & Metering Technologies (FMT) segment. In second-quarter 2026, HST organic sales rose 12% and organic orders increased 47%, extending backlog visibility into 2027. FMT organic sales increased 1% and orders rose 11%, with water and mining gains partly offset by energy, agriculture and chemical softness. The company raised its 2026 organic sales growth outlook to 5-6% from 3-4%, supported by a larger HST order book and improving demand in its industrial businesses. This mix of secular and industrial demand is expected to support IDEX’s growth beyond the latest quarter.
Accretive Acquisition: IDEX continues to undertake acquisitions to expand its technology portfolio and reach higher-value markets. In second-quarter 2026, acquisitions added 1% to consolidated sales growth and 2% to HST sales growth, reflecting Micro-LAM, acquired in July 2025. Consolidated organic sales also rose 5% in second-quarter 2026, alongside the 1% acquisition/divestiture contribution. Micro-LAM expands IDEX’s optics technology offerings within HST. The September 2024 acquisition of Mott for $1 billion added applied materials science capabilities and broadened the company’s exposure to semiconductor fabrication, medical technologies and water purification.
In the past year, the company’s shares have gained 36.2% against the industry‘s 0.7% decline.
Image Source: Zacks Investment Research
Rewards to Shareholders: IEX is committed to returning value to shareholders through dividend payments and share repurchases. In second-quarter 2026, the company paid about $54 million in dividends and repurchased $77 million of shares. For the first six months of 2026, dividend payments totaled $106.7 million compared with $105.9 million a year earlier, while cash paid for share repurchases increased to $153.4 million from $100 million.
Estimate Revisions: The Zacks Consensus Estimate for IEX’s 2026 earnings is pegged at $8.82 per share, indicating an increase of 3.9% from the 60-day-ago figure. The consensus estimate for 2027 earnings is pegged at $9.68 per share, indicating a rise of 24.6% in the same period.
Other Stocks to Consider
Some other top-ranked companies from the same space are discussed below:
Generac Holdings Inc. (GNRC - Free Report) presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The company delivered a trailing four-quarter average earnings surprise of 13.7%. In the past 60 days, the consensus estimate for GNRC’s 2026 earnings has increased 8.5%.
Applied Industrial Technologies (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). It has a trailing four-quarter average earnings surprise of 4.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2027 earnings has increased 1.7% in the past 60 days.
Helios Technologies (HLIO - Free Report) currently carries a Zacks Rank of 2. HLIO delivered a trailing four-quarter average earnings surprise of 13.1%.
In the past 60 days, the Zacks Consensus Estimate for Helios Technologies’ 2026 earnings has increased 10.4%.